Cross Historical Income Statement

CCRN Stock

USD 16.74 1.16 6.48%

Historical analysis of Cross Country income statement accounts such as Interest Expense of 5.9 M, Selling General Administrative of 318.6 M or Total Revenue of 2.1 B can show how well Cross Country Healthcare performed in making a profits. Evaluating Cross Country income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cross Country's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cross Country Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cross Country Healthcare is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Cross Income Statement Analysis

Cross Country Healthcare Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cross Country shareholders. The income statement also shows Cross investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cross Country Income Statement Chart

Cross Country Healthcare Income Statement is one of the three primary financial statements used for reporting Cross's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cross Country Healthcare revenue and expense. Cross Country Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Cross Country's Cost Of Revenue is very stable compared to the past year. As of the 3rd of May 2024, Income Before Tax is likely to grow to about 108 M, while Depreciation And Amortization is likely to drop about 12.6 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Reconciled Depreciation

Total Revenue

Total revenue comprises all receipts Cross Country Healthcare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Cross Country Healthcare minus its cost of goods sold. It is profit before Cross Country operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cross Country Healthcare. It is also known as Cross Country overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Cross Country's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cross Country Healthcare current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Gross Profit	375.0M	627.7M	432.1M	216.1M
Total Revenue	1.7B	2.8B	2.0B	2.1B

Gross Profit Total Revenue

Cross Country income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.87	0.74	0.88	0.96	0.87	0.91	0.9	0.91	0.88	0.86	0.89	0.07	0.84	0.65	-0.17	0.78	0.3	0.12	-0.25	0.72	-0.47	-0.69	0.45	0.71
Interest Expense	0.87		0.81	0.86	0.93	0.85	0.82	0.9	0.9	0.86	0.83	0.79	-0.11	0.75	0.58	-0.29	0.69	0.4	-0.1	-0.16	0.69	-0.49	-0.73	0.41	0.54
Selling General Administrative	0.74	0.81		0.93	0.8	0.93	0.75	0.88	0.88	0.92	0.74	0.72	-0.12	0.68	0.54	-0.41	0.71	0.5	-0.05	-0.18	0.65	-0.65	-0.73	0.68	0.69
Total Revenue	0.88	0.86	0.93		0.9	1.0	0.94	0.94	0.94	1.0	0.84	0.92	0.09	0.87	0.67	-0.19	0.88	0.31	0.01	-0.39	0.76	-0.53	-0.86	0.58	0.69
Gross Profit	0.96	0.93	0.8	0.9		0.89	0.89	0.92	0.93	0.9	0.91	0.87	0.02	0.84	0.59	-0.23	0.81	0.35	0.03	-0.27	0.67	-0.51	-0.72	0.46	0.61
Other Operating Expenses	0.87	0.85	0.93	1.0	0.89		0.94	0.92	0.93	1.0	0.84	0.92	0.09	0.87	0.67	-0.16	0.88	0.32	0.02	-0.39	0.77	-0.53	-0.86	0.6	0.7
Operating Income	0.91	0.82	0.75	0.94	0.89	0.94		0.88	0.89	0.94	0.82	0.99	0.29	0.95	0.7	0.02	0.93	0.09	0.06	-0.51	0.76	-0.35	-0.85	0.4	0.58
Ebit	0.9	0.9	0.88	0.94	0.92	0.92	0.88		1.0	0.93	0.73	0.87	0.05	0.83	0.61	-0.43	0.84	0.28	-0.02	-0.37	0.67	-0.47	-0.77	0.39	0.58
Ebitda	0.91	0.9	0.88	0.94	0.93	0.93	0.89	1.0		0.94	0.74	0.88	0.05	0.84	0.62	-0.41	0.84	0.28	-0.01	-0.36	0.68	-0.47	-0.77	0.4	0.6
Cost Of Revenue	0.88	0.86	0.92	1.0	0.9	1.0	0.94	0.93	0.94		0.83	0.92	0.09	0.87	0.67	-0.18	0.88	0.3	0.02	-0.4	0.77	-0.52	-0.86	0.59	0.69
Total Operating Expenses	0.86	0.83	0.74	0.84	0.91	0.84	0.82	0.73	0.74	0.83		0.79	-0.01	0.77	0.54	0.06	0.72	0.44	0.07	-0.15	0.65	-0.57	-0.67	0.62	0.64
Income Before Tax	0.89	0.79	0.72	0.92	0.87	0.92	0.99	0.87	0.88	0.92	0.79		0.36	0.96	0.67	0.04	0.95	0.03	0.12	-0.56	0.72	-0.33	-0.86	0.34	0.53
Total Other Income Expense Net	0.07	-0.11	-0.12	0.09	0.02	0.09	0.29	0.05	0.05	0.09	-0.01	0.36		0.39	0.11	0.33	0.45	-0.74	0.43	-0.62	0.03	0.29	-0.26	-0.18	-0.19
Net Income	0.84	0.75	0.68	0.87	0.84	0.87	0.95	0.83	0.84	0.87	0.77	0.96	0.39		0.46	0.07	0.96	0.05	0.14	-0.54	0.53	-0.4	-0.75	0.22	0.46
Income Tax Expense	0.65	0.58	0.54	0.67	0.59	0.67	0.7	0.61	0.62	0.67	0.54	0.67	0.11	0.46		-0.03	0.55	0.06	-0.01	-0.32	0.95	-0.05	-0.79	0.57	0.53
Selling And Marketing Expenses	-0.17	-0.29	-0.41	-0.19	-0.23	-0.16	0.02	-0.43	-0.41	-0.18	0.06	0.04	0.33	0.07	-0.03		-0.01	-0.28	0.18	-0.13	-0.01	0.2	-0.02	-0.1	-0.15
Net Income From Continuing Ops	0.78	0.69	0.71	0.88	0.81	0.88	0.93	0.84	0.84	0.88	0.72	0.95	0.45	0.96	0.55	-0.01		-0.01	0.15	-0.61	0.56	-0.35	-0.8	0.28	0.44
Non Recurring	0.3	0.4	0.5	0.31	0.35	0.32	0.09	0.28	0.28	0.3	0.44	0.03	-0.74	0.05	0.06	-0.28	-0.01		-0.05	0.53	0.16	-0.78	0.0	0.47	0.54
Non Operating Income Net Other	0.12	-0.1	-0.05	0.01	0.03	0.02	0.06	-0.02	-0.01	0.02	0.07	0.12	0.43	0.14	-0.01	0.18	0.15	-0.05		0.05	-0.03	-0.38	0.04	0.01	0.17
Minority Interest	-0.25	-0.16	-0.18	-0.39	-0.27	-0.39	-0.51	-0.37	-0.36	-0.4	-0.15	-0.56	-0.62	-0.54	-0.32	-0.13	-0.61	0.53	0.05		-0.3	-0.34	0.57	0.05	0.03
Tax Provision	0.72	0.69	0.65	0.76	0.67	0.77	0.76	0.67	0.68	0.77	0.65	0.72	0.03	0.53	0.95	-0.01	0.56	0.16	-0.03	-0.3		-0.17	-0.84	0.66	0.63
Interest Income	-0.47	-0.49	-0.65	-0.53	-0.51	-0.53	-0.35	-0.47	-0.47	-0.52	-0.57	-0.33	0.29	-0.4	-0.05	0.2	-0.35	-0.78	-0.38	-0.34	-0.17		0.17	-0.42	-0.57
Net Interest Income	-0.69	-0.73	-0.73	-0.86	-0.72	-0.86	-0.85	-0.77	-0.77	-0.86	-0.67	-0.86	-0.26	-0.75	-0.79	-0.02	-0.8	0.0	0.04	0.57	-0.84	0.17		-0.49	-0.41
Reconciled Depreciation	0.45	0.41	0.68	0.58	0.46	0.6	0.4	0.39	0.4	0.59	0.62	0.34	-0.18	0.22	0.57	-0.1	0.28	0.47	0.01	0.05	0.66	-0.42	-0.49		0.72
Extraordinary Items	0.71	0.54	0.69	0.69	0.61	0.7	0.58	0.58	0.6	0.69	0.64	0.53	-0.19	0.46	0.53	-0.15	0.44	0.54	0.17	0.03	0.63	-0.57	-0.41	0.72

Click cells to compare fundamentals

Cross Country Account Relationship Matchups

Cross Country income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	14.1M	12.7M	21.2M	31.7M	18.3M	12.6M
Interest Expense	5.3M	2.9M	6.9M	14.4M	8.1M	5.9M
Selling General Administrative	174.1M	167.6M	205.8M	308.1M	303.5M	318.6M
Total Revenue	822.2M	836.4M	1.7B	2.8B	2.0B	2.1B
Gross Profit	204.0M	202.7M	375.0M	627.7M	432.1M	216.1M
Other Operating Expenses	814.2M	820.2M	1.5B	2.5B	1.9B	2.0B
Operating Income	8.0M	16.0M	139.3M	273.1M	117.1M	123.0M
Ebit	8.0M	16.0M	139.3M	273.1M	117.1M	123.0M
Ebitda	22.1M	28.6M	160.5M	304.8M	135.5M	142.2M
Cost Of Revenue	618.2M	633.7M	1.3B	2.2B	1.6B	1.7B
Total Operating Expenses	196.0M	186.5M	225.1M	336.8M	315.0M	184.5M
Income Before Tax	(24.2M)	(12.3M)	133.2M	256.3M	102.9M	108.0M
Total Other Income Expense Net	(32.3M)	(28.3M)	(6.1M)	(16.8M)	(14.2M)	(14.9M)
Net Income	(55.9M)	(12.1M)	132.0M	188.5M	72.6M	76.3M
Income Tax Expense	31.7M	(188K)	1.2M	67.9M	30.3M	31.8M
Net Income Applicable To Common Shares	(57.7M)	(13.0M)	132.0M	188.5M	216.7M	227.6M
Selling And Marketing Expenses	7.9M	6.2M	9.5M	16.1M	11.5M	11.2M
Net Income From Continuing Ops	(55.9M)	(12.1M)	132.0M	188.5M	102.4M	107.5M
Non Recurring	23.8M	25.3M	9.5M	17.1M	19.6M	16.1M
Non Operating Income Net Other	(3.2M)	(280K)	770K	(2.4M)	(2.8M)	(2.9M)
Minority Interest	1.3M	1.2M	1.8M	820K	(210K)	0.0
Tax Provision	31.7M	(188K)	1.2M	67.9M	33.9M	35.6M
Net Interest Income	(5.3M)	(2.9M)	(6.9M)	(14.4M)	(11.0M)	(11.6M)
Reconciled Depreciation	14.1M	12.7M	9.9M	12.6M	17.0M	13.9M

Pair Trading with Cross Country

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cross Stock

0.67

ZJYL

JIN MEDICAL INTERNATIONAL

Pair Corr

Moving against Cross Stock

0.71	OGN	Organon	Pair Corr
0.62	OMI	Owens Minor Earnings Call Today	Pair Corr
0.58	VKTX	Viking Therapeutics	Pair Corr
0.54	GCTK	GlucoTrack	Pair Corr
0.51	LMAT	LeMaitre Vascular Financial Report 7th of May 2024	Pair Corr

The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.

The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:

How To Invest In Cross

Details

Is Cross Stock a good investment?

Details

What is Cross Country's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Cross Stock analysis

When running Cross Country's price analysis, check to measure Cross Country's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cross Country is operating at the current time. Most of Cross Country's value examination focuses on studying past and present price action to predict the probability of Cross Country's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cross Country's price. Additionally, you may evaluate how the addition of Cross Country to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.

Is Cross Country's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.75)

Earnings Share

2.05

Revenue Per Share

57.447

Quarterly Revenue Growth

(0.34)

Return On Assets

0.09

The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cross Historical Income Statement

About Cross Income Statement Analysis

Cross Country Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Cross Country income statement Correlations

Cross Country Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cross Country income statement Accounts

Pair Trading with Cross Country

Moving together with Cross Stock

Moving against Cross Stock

Complementary Tools for Cross Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 0.99	Operating Income
Gross Profit	+ 0.96	Depreciation And Amortization

Net Interest Income	- 0.86	Income Before Tax
Net Interest Income	- 0.86	Cost Of Revenue
Net Interest Income	- 0.86	Other Operating Expenses
Net Interest Income	- 0.86	Total Revenue
Net Interest Income	- 0.85	Operating Income
Net Interest Income	- 0.84	Tax Provision